PET imaging for evaluation of metastatic colorectal cancer of the liver

European Journal of Radiology

Volumn 58, Issue 2, 2006, Pages 229-235

  Erturk, Sukru Mehmet ^a   Ichikawa, Tomoaki ^a   Fujii, Hirofumi ^b   Yasuda, Seiei ^c   Ros, Pablo R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c TOKAI UNIVERSITY   (Japan)

Author keywords

Colorectal metastases; Liver; PET; PET CT

Indexed keywords

COMPUTERIZED TOMOGRAPHY; HEALTH CARE; MAGNETIC RESONANCE IMAGING; PATIENT TREATMENT; POLYETHYLENE TEREPHTHALATES; TUMORS;

COLORECTAL METASTASES; LIVER; PET-CT;

BIOLOGICAL ORGANS;

CARCINOEMBRYONIC ANTIGEN; FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; IRINOTECAN; MANGAFODIPIR; OXALIPLATIN;

ARTICLE; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER THERAPY; CHEMOEMBOLIZATION; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; ECHOGRAPHY; EVALUATION; FOLLOW UP; HUMAN; LIVER; LIVER METASTASIS; LIVER RESECTION; LOCAL THERAPY; METABOLISM; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RECURRENT DISEASE; SENSITIVITY AND SPECIFICITY; SYSTEMIC THERAPY; TREATMENT RESPONSE; TUMOR CELL; UNITED STATES; WESTERN EUROPE;

AGED; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, X-RAY COMPUTED;

EID: 33646082250     PISSN: 0720048X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejrad.2005.11.042     Document Type: Article

References (53)

1. Vauthey J.N. Liver imaging: a surgeon's perspective. Radiol Clin N Am 36 (1998) 445-457
2. Greenway B. Hepatic metastases from colorectal cancer: resection or not?. Br J Surg 75 (1988) 513-519
3. Sugarbaker P.H. Surgical management decision making for large bowel cancer metastatic to the liver. Radiology 174 (1990) 621-626
4. Fong Y. Surgical therapy of hepatic colorectal metastasis. Cancer J Clin 49 4 (1999) 231-255
5. Abdel-Nabi H., Doerr R.J., Lamonica D.M., et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 206 (1998) 755-760
6. Arulampalam T.H., Francis D.L., Visvikis D., Taylor I., and Ell P.J. FDG-PET for the pre-operative evaluation of colorectal liver metastases. Eur J Surg Oncol 30 3 (2004) 286-291
7. Selzner M., and Clavien P.A. Resection of liver tumors: special emphasis on neoadjuvant and adjuvant therapy. In: Clavien P.A. (Ed). Malignant liver tumors: current and emerging therapies (1999), Blackwell Science, Malden 137-149
8. Belghiti J., Hiramatsu K., Benoist S., et al. Seven hundred and forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191 (2000) 38-46
9. Clavien P.A., Selzner M., Rüdiger H., et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with vs. without ischemic preconditioning. Ann Surg 238 (2003) 843-852
10. Selzner M., Hany T.F., Wildbrett P., McCormack L., Kadry Z., and Clavien P.A. Does the novel PET/CT imaging modality impact on the treatment of patients with metastatic colorectal cancer of the liver?. Ann Surg 240 6 (2004) 1027-1034
11. Taylor I. Liver metastases from colorectal cancer: lessons from past and present clinical studies. Br J Surg 83 4 (1996) 456-460
12. Scheele J., Stangl R., Altendorf-Hofmann A., and Gall F.P. Indicators of prognosis after hepatic resection for colorectal secondaries. Surgery 110 1 (1991) 13-29
13. Bines S.D., Doolas A., Jenkins L., Millikan K., and Roseman D.L. Survival after repeat hepatic resection for recurrent colorectal hepatic metastases. Surgery 120 4 (1996) 591-596
14. Pinson C.W., Wright J.K., Chapman W.C., Garrard C.L., Blair T.H., and Sawyers J.L. Repeat hepatic surgery for colorectal cancer metastasis to the liver. Ann Surg 223 6 (1996) 765-773
15. Adson M.A., Van Heerden J.A., Adson M.H., et al. Resection of hepatic metastases from colorectal cancer. Arch Surg 119 (1984) 647-651
16. Scheele J., Stangl R., and Altendorf-Hofman A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77 (1990) 1241-1246
17. Jarnagin W.R., Fong Y., Ky A., et al. Liver resection for metastatic colorectal cancer: assessing the risk of occult irresectable disease. J Am Coll Surg 188 (1999) 33-42
18. Donckier V., Van Laethem J.L., Goldman S., et al. [F-18] fluorodeoxyglucose positron emission tomography as a tool for early recognition of incomplete tumor destruction after radiofrequency ablation for liver metastases. J Surg Oncol 84 4 (2003) 215-223
19. Delbeke D., and Martin W.H. PET and PET-CT for evaluation of colorectal carcinoma. Semin Nucl Med 34 3 (2004) 209-223
20. Liu L.X., Zhang W.H., and Jiang H.C. Current treatment for liver metastases from colorectal cancer. World J Gastroenterol 9 (2003) 193-200
21. Ruers T., and Bleichrodt R.P. Treatment of liver metastases, an update on the possibilities and results. Eur J Cancer 38 (2002) 1023-1033
22. Gray B., Van Hazel G., and Hope M. Randomized trial of Sir-spheres plus chemotherapy vs chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 12 (2001) 1711-1720
23. Nijsen J.F., van het Schip A.D., and Hennink W.E. Advances in nuclear oncology: microspheres for internal radionuclide therapy of liver tumours. Curr Med Chem 9 (2002) 73-82
24. Langenhoff B.S., Oyen W.J., Jager G.J., et al. Efficacy of fluorine-18-deoxyglucose positron emission tomography in detecting tumor recurrence after local ablative therapy for liver metastases: a prospective study. J Clin Oncol 20 22 (2002) 4453-4458
25. Zealley I.A., Skehan S.J., Rawlinson J., Coates G., Nahmias C., and Somers S. Selection of patients for resection of hepatic metastases: improved detection of extrahepatic disease with FDG PET. Radiographics 21 (2001) S55-S69
26. Huebner R.H., Park K.C., Shepherd J.E., et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 41 7 (2000) 1177-1189
27. Kapoor V., McCook B.M., and Torok F.S. An introduction to PET-CT imaging. Radiographics 24 2 (2004) 523-543
28. Tutt A.N., Plunkett T.A., Barrington S.F., and Leslie M.D. The role of positron emission tomography in the management of colorectal cancer. Colorectal Dis 6 1 (2004) 2-9
29. Soyer P., Levesque M., and Elias D. Detection of liver metastases from colorectal cancer: comparison of intraoperative US and CT during arterial portography. Radiology 183 (1992) 541-544
30. Nelson R.C., Chezmar J.L., and Sugarbaker P.H. Hepatic tumors: comparison of CT during arterial portography, delayed CT and MR imaging for preoperative evaluation. Radiology 172 (1989) 27-34
31. Small W.C., Mehard W.B., and Langmo L.S. Preoperative determination of the resectability of hepatic tumors: efficacy of CT during arterial portography. AJR 161 (1993) 319-322
32. Peterson M.S., Baron R.L., and Dodd G.D. Hepatic parenchymal perfusion detected with CTPA: imaging-pathologic correlation. Radiology 183 (1992) 149-155
33. Kitapci M.T., and Coleman R.E. Colorectal cancer. In: Oehr P., Biersack H.J., and Coleman R.E. (Eds). PET and PET-CT in oncology (2004), Springer, Berlin 213-227
34. Delbeke D., Vitola J.V., Sandler M.P., et al. Staging recurrent metastatic colorectal carcinoma with PET. J Nucl Med 38 8 (1997) 1196-1201
35. Topal B., Flamen P., Aerts R., et al. Clinical value of whole-body emission tomography in potentially curable colorectal liver metastases. Eur J Surg Oncol 27 2 (2001) 175-179
36. Bohm B., Voth M., Geoghegan J., et al. Impact of positron emission tomography on strategy in liver resection for primary and secondary liver tumors. J Cancer Res Clin Oncol 130 5 (2004) 266-272
37. Ogunbiyi O.A., Flanagan F.L., Dehdashti F., et al. Detection of recurrent and metastatic colorectal cancer: comparison of positron emission tomography and computed tomography. Ann Surg Oncol 4 8 (1997) 613-620
38. Kinkel K., Lu Y., Both M., Warren R.S., and Thoeni R.F. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology 224 3 (2002) 748-756
39. Sahani D.V., Kalva S.P., Fischman A.J., et al. Detection of liver metastases from adenocarcinoma of the colon and pancreas: comparison of mangafodipir trisodium-enhanced liver MRI and whole-body FDG PET. AJR Am J Roentgenol 185 1 (2005) 239-246
40. Truant S., Huglo D., Hebbar M., Ernst O., Steinling M., and Pruvot F.R. Prospective evaluation of the impact of [18F]fluoro-2-deoxy-d-glucose positron emission tomography of resectable colorectal liver metastases. Br J Surg 92 3 (2005) 362-369
41. Yang M., Martin D.R., Karabulut N., and Frick M.P. Comparison of MR and PET imaging for the evaluation of liver metastases. J Magn Reson Imaging 17 3 (2003) 343-349
42. Lai D.T., Fulham M., Stephen M.S., et al. The role of whole-body positron emission tomography with [18F]fluorodeoxyglucose in identifying operable colorectal cancer metastases to the liver. Arch Surg 131 7 (1996) 703-707
43. Moehler M., Dimitrakopoulou-Strauss A., Gutzler F., Raeth U., Strauss L.G., and Stremmel W. 18F-labeled fluorouracil positron emission tomography and the prognoses of colorectal carcinoma patients with metastases to the liver treated with 5-fluorouracil. Cancer 83 2 (1998) 245-253
44. Vitola J.V., Delbeke D., and Meranze S.G. Positron emission tomography with F-18-fluorodeoxyglucose to evaluate the results of hepatic chemoembolization. Cancer 78 (1996) 2216-2222
45. Torizuka T., Tamaki N., Inokuma T., et al. Value of fluorine-18-FDG-PET to monitor hepatocellular carcinoma after interventional therapy. J Nucl Med 35 12 (1994) 1965-1969
46. Barker D.W., Zagoria R.J., Morton K.A., Kavanagh P.V., and Shen P. Evaluation of liver metastases after radiofrequency ablation: utility of 18F-FDG PET and PET/CT. Am J Roentgenol 184 4 (2005) 1096-1102
47. Veit P, Antoch G, Stergar H, Bockisch A, Forsting M, Kuehl H. Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results. Eur Radiol 2005; Epub ahead of print.
48. Antoch G., Vogt F.M., Veit P., et al. Assessment of liver tissue after radiofrequency ablation: findings with different imaging procedures. J Nucl Med 46 3 (2005) 520-525
49. 18F-FDG PET. J Nucl Med 45 11 (2004) 1892-1897
50. Braga L., Guller U., and Semelka R.C. Modern hepatic imaging. Surg Clin N Am 84 2 (2004) 375-400
51. Ruers T.J., Langenhoff B.S., Neeleman N., et al. Value of positron emission tomography with [F-18]fluorodeoxyglucose in patients with colorectal liver metastases: a prospective study. J Clin Oncol 20 2 (2002) 388-395
52. Israel O. PET-CT. In: Wahl R.L. (Ed). Principles and practice of positron emission tomography (2002), Lippincott, Williams and Wilkins, Philadelphia 268-275
53. Cohade C., Osman M., Leal J., and Wahl R.L. Direct comparison of (18)F-FDG PET and PET/CT in patients with colorectal carcinoma. J Nucl Med 44 11 (2003) 1797-1803